Tip: Index histories & All-time highs

Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 23.09.2024       Springer Nature AG & Co. KGaA
DE000SPG1003

  NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE.PRESS RELEASE Springer Nature sets price range for [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Hardman & Co Research
GB00B5SGVL29

Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit   TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue  [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Hardman & Co Research
GB00B5SGVL29

Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit   TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue  [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Implenia AG
CH0023868554

Implenia AG / Key word(s): Investment/Letter of Intent Implenia welcomes talks about possible merger of Ina Invest and Cham Group 23.09.2024 / 07:05 CET/CEST Implenia acknowledges examination of a possible merger between Ina Invest and Cham Group and welcomes talks Glattpark (Opfikon), 23 September 2024 – Swiss property [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Implenia AG
CH0023868554

Implenia AG / Key word(s): Investment/Letter of Intent Implenia welcomes talks about possible merger of Ina Invest and Cham Group 23.09.2024 / 07:05 CET/CEST Implenia acknowledges examination of a possible merger between Ina Invest and Cham Group and welcomes talks Glattpark (Opfikon), 23 September 2024 – Swiss property [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Ina Invest AG
CH0524026959

Ad hoc announcement pursuant to Art. 53 LR Zurich, September 23, 2024 – Ina Invest, the Swiss real estate company listed on the Six Swiss Exchange, is considering a merger with the OTC traded real estate company Cham Group. The merger is to be carried out as a merger of equals. A corresponding letter of intent has been signed by the boards of direc [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Ina Invest AG
CH0524026959

Ad hoc announcement pursuant to Art. 53 LR Zurich, September 23, 2024 – Ina Invest, the Swiss real estate company listed on the Six Swiss Exchange, is considering a merger with the OTC traded real estate company Cham Group. The merger is to be carried out as a merger of equals. A corresponding letter of intent has been signed by the boards of direc [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Relief Therapeutics Holding SA
CH1251125998

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement GENEVA (SEPT. 23, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it will r [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Relief Therapeutics Holding SA
CH1251125998

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement GENEVA (SEPT. 23, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it will r [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Leclanché SA
CH0110303119

Leclanché SA / Key word(s): Market Launch Leclanché Launches XN50, World’s First Li-ion Commercial Cell Featuring Echion Technologies’ XNO® 23.09.2024 / 06:00 CET/CEST Leclanché Launches XN50, World’s First Li-ion Commercial Cell Featuring Echion Technologies’ XNO® Leclanché unveils the world’s first lithium-ion (Li-i [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 27.11.2024, Calendar Week 48, 332nd day of the year, 34 days remaining until EoY.